Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076355128> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2076355128 abstract "Purpose To assess the safety and efficiency of an subretinal injection of an AAV2/4.rpe65.hrpe65 in subjects with LCA due to mutations rpe65 genes.Methods A phase I/II clinical trial assessed the safety and the efficiency of one subretinal injection with AAV2/4.rpe65.hrep65 vector in the worse eye of patient with rpe65-/- retinal dystrophy. Patients of the first cohort received up to 400 µL and patients of the second cohort up to 800 µL of a vector solution at 6.1010 vector genome/mL. The primary safety endpoints are evaluated by biomicroscopy, laser flare meter, fundus photography, fluorescein angiography, OCT and a tolerance questionnaire. Secondary efficacy endpoints are evaluated by global ERG, multifocal ERG, visual field, near and far visual acuity, color vision test, pupillometry, microperimetry, visual mobility, functional MRI and fundus autofluorescence.Results We will present results of the first six patients included in an ongoing study. Patients are 21 to 42 years old. The three first patients were included in the first cohort and three other were included in the second cohort. No adverse effects or ocular inflammation are noticed one year to 2 months after subretinal injection. Visual acuity is limited to light perception to 1/12 and remained stable after subretinal injection. Visual field modifications in the subretinal treated area are noticed in all patients.Conclusion subretinal injection of a serotype 4 AAV vector for gene therapy treatment of rpe65-/- retinal degeneration is safe. Visual field improvement found in our adult patients want us to treat 3 childrens scheduled in the third cohort." @default.
- W2076355128 created "2016-06-24" @default.
- W2076355128 creator A5009208524 @default.
- W2076355128 creator A5027003228 @default.
- W2076355128 creator A5048002297 @default.
- W2076355128 creator A5050704861 @default.
- W2076355128 creator A5066628716 @default.
- W2076355128 creator A5070809700 @default.
- W2076355128 creator A5081601167 @default.
- W2076355128 creator A5089785088 @default.
- W2076355128 date "2012-08-06" @default.
- W2076355128 modified "2023-09-27" @default.
- W2076355128 title "Efficacy and safety of gene therapy with AAV4 in childhood blindness due to rpe65 mutations" @default.
- W2076355128 doi "https://doi.org/10.1111/j.1755-3768.2012.4223.x" @default.
- W2076355128 hasPublicationYear "2012" @default.
- W2076355128 type Work @default.
- W2076355128 sameAs 2076355128 @default.
- W2076355128 citedByCount "4" @default.
- W2076355128 countsByYear W20763551282015 @default.
- W2076355128 countsByYear W20763551282023 @default.
- W2076355128 crossrefType "journal-article" @default.
- W2076355128 hasAuthorship W2076355128A5009208524 @default.
- W2076355128 hasAuthorship W2076355128A5027003228 @default.
- W2076355128 hasAuthorship W2076355128A5048002297 @default.
- W2076355128 hasAuthorship W2076355128A5050704861 @default.
- W2076355128 hasAuthorship W2076355128A5066628716 @default.
- W2076355128 hasAuthorship W2076355128A5070809700 @default.
- W2076355128 hasAuthorship W2076355128A5081601167 @default.
- W2076355128 hasAuthorship W2076355128A5089785088 @default.
- W2076355128 hasConcept C118487528 @default.
- W2076355128 hasConcept C126322002 @default.
- W2076355128 hasConcept C2776391266 @default.
- W2076355128 hasConcept C2776474195 @default.
- W2076355128 hasConcept C2778024200 @default.
- W2076355128 hasConcept C2778257484 @default.
- W2076355128 hasConcept C2779100554 @default.
- W2076355128 hasConcept C2780248432 @default.
- W2076355128 hasConcept C2780724529 @default.
- W2076355128 hasConcept C2780827179 @default.
- W2076355128 hasConcept C71924100 @default.
- W2076355128 hasConcept C72563966 @default.
- W2076355128 hasConceptScore W2076355128C118487528 @default.
- W2076355128 hasConceptScore W2076355128C126322002 @default.
- W2076355128 hasConceptScore W2076355128C2776391266 @default.
- W2076355128 hasConceptScore W2076355128C2776474195 @default.
- W2076355128 hasConceptScore W2076355128C2778024200 @default.
- W2076355128 hasConceptScore W2076355128C2778257484 @default.
- W2076355128 hasConceptScore W2076355128C2779100554 @default.
- W2076355128 hasConceptScore W2076355128C2780248432 @default.
- W2076355128 hasConceptScore W2076355128C2780724529 @default.
- W2076355128 hasConceptScore W2076355128C2780827179 @default.
- W2076355128 hasConceptScore W2076355128C71924100 @default.
- W2076355128 hasConceptScore W2076355128C72563966 @default.
- W2076355128 hasLocation W20763551281 @default.
- W2076355128 hasOpenAccess W2076355128 @default.
- W2076355128 hasPrimaryLocation W20763551281 @default.
- W2076355128 hasRelatedWork W1755815992 @default.
- W2076355128 hasRelatedWork W1972710764 @default.
- W2076355128 hasRelatedWork W1993747607 @default.
- W2076355128 hasRelatedWork W2002337035 @default.
- W2076355128 hasRelatedWork W2086763399 @default.
- W2076355128 hasRelatedWork W2126115955 @default.
- W2076355128 hasRelatedWork W2142838015 @default.
- W2076355128 hasRelatedWork W2260846512 @default.
- W2076355128 hasRelatedWork W2339001755 @default.
- W2076355128 hasRelatedWork W2607001239 @default.
- W2076355128 hasRelatedWork W2807671115 @default.
- W2076355128 hasRelatedWork W2810681605 @default.
- W2076355128 hasRelatedWork W2890721979 @default.
- W2076355128 hasRelatedWork W2952178822 @default.
- W2076355128 hasRelatedWork W2970293522 @default.
- W2076355128 hasRelatedWork W2979162070 @default.
- W2076355128 hasRelatedWork W3023306666 @default.
- W2076355128 hasRelatedWork W3097728998 @default.
- W2076355128 hasRelatedWork W3197915620 @default.
- W2076355128 hasRelatedWork W3199767393 @default.
- W2076355128 isParatext "false" @default.
- W2076355128 isRetracted "false" @default.
- W2076355128 magId "2076355128" @default.
- W2076355128 workType "article" @default.